Fineotex Chemical Q1 FY26: ₹146.22 Cr Income, PAT ₹25.03 Cr

Stock moves as earnings details circulate

Fineotex Chemical’s share price was seen around ₹37.08 during the session, after trading at ₹38.20 (down 0.91, or 2.33%) and later ₹37.44 (down 1.50, or 3.85%) in the same stream of updates. The moves came as investors tracked multiple financial snapshots shared for different periods, including the quarter ended June 2025 and the quarter ended March 2026. The disclosures included a quarterly results table, a separate earnings note for Q1 FY26, and consolidated and standalone highlights for Q4 and FY26. Together, they show a business reporting strong consolidated growth in Q4 FY26 and FY26, while the Q1 FY26 numbers were presented through more than one dataset. For market participants, the key task is separating period, basis (consolidated vs standalone), and unit (crore vs lakh vs million) before comparing performance.

Q1 FY26 headline numbers: total income and net profit

For the first quarter ended June 30, 2025, Fineotex Chemical reported consolidated total income of ₹146.22 crore and net profit of ₹25.03 crore. The same update also reported gross profit of ₹45.96 crore, with a gross margin of 33.53%. Operational EBITDA for the quarter was cited at about ₹25.20 crore, and the update referenced sequential growth in several profitability lines. The company also stated that consolidated sales volume increased by 14.73% on a quarter-on-quarter basis. Alongside financials, the update mentioned commissioning a new state-of-the-art manufacturing facility and granting additional stock options to eligible employees.

What the quarterly results table shows for the June 2025 quarter

A separate “Quarterly - Fineotex Chemical Q1 Results” table (figures in ₹ crore, except per-share values) provided line items for the quarter ended June 2025 with quarter-on-quarter (QoQ) and year-on-year (YoY) comparison columns. In that table, total revenue for Jun 25 was ₹137.07 crore. Operating income was listed at ₹22.51 crore, net income at ₹24.81 crore, and net income before taxes at ₹31.49 crore. Total operating expense was ₹114.57 crore and depreciation/amortization was ₹2.69 crore. Diluted normalized EPS was shown at ₹0.22 for the Jun 25 quarter.

The table also showed a “Mar 26” column with total revenue of ₹313.73 crore and net income of ₹31.61 crore, and a note that the last earnings update was 31 Mar 2026. Since multiple disclosures are presented together, readers should treat each dataset as period-specific and basis-specific rather than assuming all items reconcile line by line.

Q4 FY26 consolidated performance: sharp scale-up

For Q4 FY26 (quarter ended March 2026), the company’s consolidated revenue from operations was reported at ₹313.73 crore, compared with ₹119.79 crore in Q4 FY25, implying 161.91% YoY growth. On a quarter-on-quarter basis, the Q4 FY26 revenue was reported up 70.77% from ₹183.71 crore in Q3 FY26. Consolidated total income for Q4 FY26 was ₹323.19 crore, up 153.82% YoY from ₹127.33 crore and up 69.69% QoQ from ₹190.46 crore. Consolidated profit after tax (PAT) for Q4 FY26 stood at ₹43.79 crore, up 117.55% YoY from ₹20.13 crore and up 45.42% QoQ from ₹30.12 crore.

The company’s own highlight note for Q4 FY26 (YoY) also stated that sales surged by around 162%, EBITDA grew by around 86%, and PAT increased by around 120%. These growth rates align directionally with the consolidated Q4 figures provided in the update.

FY26 consolidated: revenue growth, PAT up modestly

For the full year FY26, consolidated revenue from operations was reported at ₹772.23 crore, a 44.79% increase over ₹533.33 crore in FY25. Consolidated total income for FY26 was ₹805.30 crore, up 44.41% YoY from ₹557.64 crore. Consolidated PAT for FY26 was ₹125.02 crore, up 14.47% YoY from ₹109.21 crore. The difference between revenue growth and PAT growth is a key point investors may track in subsequent quarters, especially as the company scales up operations.

Standalone numbers: Q4 FY26 and FY26 show a different trend

The update also provided standalone performance for Q4 FY26 and FY26. Standalone revenue from operations in Q4 FY26 was ₹97.60 crore, down 9.58% YoY from ₹107.95 crore, while increasing 1.17% QoQ from ₹96.47 crore. Standalone total income in Q4 FY26 was ₹105.01 crore, down 9.16% YoY from ₹115.60 crore and down 2.54% QoQ from ₹107.75 crore. For the full year FY26, standalone revenue from operations was ₹396.88 crore, down 9.64% from ₹439.22 crore in FY25, while standalone PAT was ₹91.89 crore, down 5.49% from ₹97.23 crore.

Dividend recommendation and payout size

The board recommended a final dividend of about ₹5.82 crore at ₹0.05 per equity share (5% of face value of ₹1 each), subject to shareholder approval at the ensuing AGM. The same note stated that total dividend payout for FY26 stands at approximately ₹15 crore. For investors focused on yield and payout consistency, the AGM outcome becomes an important checkpoint because the final dividend is explicitly subject to member approval.

Operational mix and export share cited in the update

The operational commentary included a sector mix split: on a volume basis, textile was about 70% in the quarter, health and hygiene/FMCG about 25%, and drilling (oil and gas and others) about 5%. In revenue terms, textile was indicated at about 80%, with the remaining coming from hygiene, FMCG, drilling, and others. The update also stated exports were 24% of total income during the quarter. These disclosures help explain how demand changes in end-markets can flow into quarterly numbers.

Prior quarter references: Q3 FY26 and Q3 FY25 context

For Q3 FY26, the update cited total income of ₹190.46 crore versus ₹130.91 crore in Q3 FY25 (45% change), and revenue from operations of ₹183.71 crore versus ₹125.92 crore (46% change). Q3 FY26 EBITDA was reported at ₹34.84 crore versus ₹34.29 crore in Q3 FY25 (2% change), with an EBITDA margin of 19.96% in Q3 FY26. Profit before tax (PBT) was ₹38.02 crore versus ₹36.48 crore (4% change), PAT was ₹30.12 crore versus ₹27.83 crore (8% change), and PAT margin was 16.39%, with EPS of ₹0.26.

The disclosures also noted that total income in Q3 FY25 was ₹130.91 crore compared to ₹143.39 crore in Q3 FY24, a decline of 9%, and attributed the decline to muted demand in FMCG, a key sector catered to by the company.

Key figures table (all amounts in ₹ crore)

Why the numbers matter for investors tracking Fineotex

The disclosures show a company reporting sharp consolidated expansion in Q4 FY26, accompanied by strong YoY growth metrics and a higher revenue base versus the prior year. At the same time, the standalone set points to a weaker YoY trend in Q4 FY26 and FY26, highlighting the importance of monitoring which parts of the business are driving consolidated outcomes. The operational mix disclosures add another lens, since textile is described as the largest contributor, while FMCG demand was cited as muted in an earlier period. For investors, the immediate takeaway is that the story contains both scale-up signals (consolidated numbers) and softer pockets (standalone trend), which the company’s future quarterly disclosures may clarify further.

Other disclosed corporate and regulatory details

Fineotex Chemical informed BSE that its board meeting was scheduled on 13/02/2026 to consider and approve unaudited financial results for the quarter and nine months ended December 31, 2025. Separately, the company’s registered office was listed as Manorama Chambers, S V Road, Bandra (West), Mumbai, and corporate contact names were provided for the company secretary and investor relations. These details matter mainly for compliance tracking and for shareholders who follow board and results calendars closely.

Conclusion

Fineotex Chemical’s updates around Q1 FY26 highlighted consolidated total income of ₹146.22 crore and net profit of ₹25.03 crore, while additional tables and notes provided Q4 FY26 and FY26 consolidated and standalone snapshots. The board’s final dividend recommendation and stated FY26 payout add a shareholder-return angle, subject to AGM approval. With multiple period disclosures presented together, investors will likely focus on upcoming filings to see how the Q1 FY26 table set aligns with the broader consolidated trajectory reported for Q4 FY26 and FY26.